Macrophage Xanthine Oxidoreductase Links LPS Induced Lung Inflammatory Injury to NLRP3 Inflammasome Expression and

Insights

Xanthine oxidoreductase (XOR) drives inflammation in acute lung injury (ALI). Targeting macrophage-specific XOR reduces lung inflammation and injury by altering inflammatory and metabolic pathways.

Area of Science:

  • Pulmonary Medicine
  • Inflammation Research
  • Cellular Metabolism

Background:

  • Acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) are severe inflammatory lung conditions with limited treatment options.
  • Reactive oxygen species (ROS) and macrophages are key players in ALI/ARDS pathogenesis.
  • Xanthine oxidoreductase (XOR) generates ROS and is implicated in ALI-associated inflammation.

Conclusions:

  • Macrophage XOR is essential for the inflammatory response and injury development in LPS-induced ALI.
  • XOR links macrophage redox state, mitochondrial respiration (glycolysis), and inflammatory activation via the NLRP3 inflammasome.
  • Targeting macrophage XOR may offer a therapeutic strategy for ALI/ARDS.